PodParley PodParley
PodParley
Blinatumomab for B-cell ALL Relapse, IVIG for MIS-C, Review of Irritable Bowel Syndrome, and more episode artwork

EPISODE · Mar 2, 2021 · 10 MIN

Blinatumomab for B-cell ALL Relapse, IVIG for MIS-C, Review of Irritable Bowel Syndrome, and more

from JAMA Editors' Summary

Editor's Summary by Mary McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the March 2, 2021 issue

Episode metadata supplied by the publisher feed · Published Mar 2, 2021

Embed this episode

NOW PLAYING

Blinatumomab for B-cell ALL Relapse, IVIG for MIS-C, Review of Irritable Bowel Syndrome, and more

0:00 10:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 10 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on March 2, 2021.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!